Stock Alert: Clean Energy Fuels Corp. Adds 30% After Striking Deal With LA Metro

By RTTNews Staff Writer   ✉   | Published:

Shares of Clean Energy Fuels Corp. (CLNE) are rising more than 30% Monday morning after the company signed deal with Los Angeles County Metropolitan Transportation Authority.

As per the agreement, Clean Energy will supply about 47.5 million gallons of renewable natural gas (RNG) to LA metro, the nation's largest transit bus fleet.

"Metro continues to lead public transportation as one of the cleanest fleets in the US, with nearly 22 million gallons of RNG delivered to Metro since 2017," said Clean Energy Renewables Senior Vice President, Nate Jensen. "With this additional commitment to fuel with Clean Energy's RNG, Metro is accelerating its path to net zero carbon emissions through RNG and other alternative fuels."

CLNE touched a new high of $17.27 this morning.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amazon warehouse workers in Alabama are starting their mail-in voting on unionization Monday after the National Labor Relations Board or NLRB rejected the company's request for a delay in election. The regulator will mail ballots to around 6,000 workers at the warehouse starting Monday to decide whether to unionize, and the ballots must be returned by March 29. The U.S. Food and Drug Administration approved a new treatment for adult patients with certain types of large B-cell lymphoma (LBCL) who have not responded to, or who have relapsed after, at least two other types of systemic treatment. Bristol-Myers Squibb's Breyanzi (lisocabtagene maraleucel) is the third gene therapy to be approved by the FDA for Large-B-Cell Lymphoma. South Africa has halted the rollout of AstraZeneca- Oxford vaccine against Covid-19 after a study showed the vaccine provided minimal protection against a new variant. South African Health Minister Zweli Mkhize, while speaking at a news conference on Sunday, said there is a temporary hold as the government waits for further advice on how to proceed with the AstraZeneca- Oxford vaccine...